RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S
4,1800
30-мая-25 13:45:00
15 мин. задержка
Акции
-0,2700
-6,07%
Сегодняшний диапазон
4,1100 - 4,3600
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
09 май 2024 13:01:00 Источник Nasdaq GlobeNewswire
-
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
02 май 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conferences
01 май 2024 05:01:00 Источник Nasdaq GlobeNewswire
-
30 апр 2024 05:00:01 Источник Nasdaq GlobeNewswire
-
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
16 апр 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conference
02 апр 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Recursion Publishes Annual Environmental, Social and Governance Report
26 мар 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Recursion Announces Plans to Open New Office in London
11 мар 2024 01:00:00 Источник Nasdaq GlobeNewswire
-
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
01 мар 2024 11:58:00 Источник Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conferences
01 мар 2024 04:59:00 Источник Nasdaq GlobeNewswire
-
27 фев 2024 13:05:11 Источник Nasdaq GlobeNewswire
-
Recursion to Host Public L(earnings) Call on February 27
20 фев 2024 04:59:00 Источник Nasdaq GlobeNewswire
-
Altitude Lab Startups Raise Over $120M in Capital
24 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
08 янв 2024 07:59:00 Источник Nasdaq GlobeNewswire
-
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
04 янв 2024 04:59:00 Источник Nasdaq GlobeNewswire
-
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
03 янв 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
20 дек 2023 04:59:00 Источник Nasdaq GlobeNewswire
-
Bayer and Recursion Focus Research Collaboration on Oncology
09 ноя 2023 06:41:30 Источник Nasdaq GlobeNewswire
-
09 ноя 2023 05:01:00 Источник Nasdaq GlobeNewswire
-
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
09 ноя 2023 04:58:00 Источник Nasdaq GlobeNewswire